{"transactions":[{"id":1352335,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2024-11-25T21:36:36.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":18641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest one year from date of grant."}],"balance_after":18641,"derivative":{"exercise_price":8.24,"expiration_date":"2034-11-21","underlying":"Common Shares","underlying_shares":18641},"source":{"system":"sec-edgar","filing":"0001600620-24-000124","document":"wk-form4_1732570590.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000124/wk-form4_1732570590.xml","form_type":"4"}},{"id":1352334,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-11-25T21:36:36.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":12135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant."}],"balance_after":25053,"source":{"system":"sec-edgar","filing":"0001600620-24-000124","document":"wk-form4_1732570590.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000124/wk-form4_1732570590.xml","form_type":"4"}},{"id":1505073,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-22T20:09:46.000Z","date":"2024-05-21","kind":"sale","planned":false,"acquired":false,"shares":5610,"price":5.74,"value":32201.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on May 19, 2023."}],"balance_after":12918,"source":{"system":"sec-edgar","filing":"0001600620-24-000072","document":"wk-form4_1716408574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000072/wk-form4_1716408574.xml","form_type":"4"}},{"id":1880735,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-23T21:14:54.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":15234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in twelve equal monthly installments commencing on June 19, 2023."}],"balance_after":15234,"derivative":{"exercise_price":10.74,"expiration_date":"2033-05-19","underlying":"Common Stock","underlying_shares":15234},"source":{"system":"sec-edgar","filing":"0001600620-23-000017","document":"wk-form4_1684876480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000017/wk-form4_1684876480.xml","form_type":"4"}},{"id":1880734,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-23T21:14:54.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":false,"shares":8733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date."}],"balance_after":0,"derivative":{"exercise_date":"2023-05-18","underlying":"Common Stock","underlying_shares":8733},"source":{"system":"sec-edgar","filing":"0001600620-23-000017","document":"wk-form4_1684876480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000017/wk-form4_1684876480.xml","form_type":"4"}},{"id":1880733,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:14:54.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":4815,"price":11.26,"value":54216.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":18528,"source":{"system":"sec-edgar","filing":"0001600620-23-000017","document":"wk-form4_1684876480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000017/wk-form4_1684876480.xml","form_type":"4"}},{"id":1880732,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:14:54.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":9310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of the RSUs payable solely in common stock of the Issuer. The shares subject to the RSUs shall vest one year from date of grant."}],"balance_after":23343,"source":{"system":"sec-edgar","filing":"0001600620-23-000017","document":"wk-form4_1684876480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000017/wk-form4_1684876480.xml","form_type":"4"}},{"id":1880731,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:14:54.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":true,"shares":8733,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date."}],"balance_after":14033,"source":{"system":"sec-edgar","filing":"0001600620-23-000017","document":"wk-form4_1684876480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000017/wk-form4_1684876480.xml","form_type":"4"}},{"id":2261409,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T20:08:11.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":14612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve equal monthly installments commencing on June 18, 2022."}],"balance_after":14612,"derivative":{"exercise_price":11.45,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":14612},"source":{"system":"sec-edgar","filing":"0001628280-22-015030","document":"wf-form4_165307726912108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022015030/wf-form4_165307726912108.xml","form_type":"4"}},{"id":2261408,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-20T20:08:11.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":8733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."}],"balance_after":8733,"derivative":{"underlying":"Common Shares","underlying_shares":8733},"source":{"system":"sec-edgar","filing":"0001628280-22-015030","document":"wf-form4_165307726912108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022015030/wf-form4_165307726912108.xml","form_type":"4"}},{"id":2471196,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-15T21:09:55.000Z","date":"2021-12-13","kind":"purchase","acquired":true,"shares":1600,"price":20.04,"value":32064.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $20.02 to $20.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":5300,"source":{"system":"sec-edgar","filing":"0001628280-21-025130","document":"wf-form4_163960257768858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021025130/wf-form4_163960257768858.xml","form_type":"4"}},{"id":2665530,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T01:16:03.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":31347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on July 14, 2021."}],"balance_after":31347,"derivative":{"exercise_price":12.86,"expiration_date":"2031-06-14","underlying":"Common Shares","underlying_shares":31347},"source":{"system":"sec-edgar","filing":"0001628280-21-012383","document":"wf-form4_162389253984760.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021012383/wf-form4_162389253984760.xml","form_type":"4"}},{"id":2715831,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-12T20:28:17.000Z","date":"2021-05-11","kind":"purchase","acquired":true,"shares":2500,"price":10.9557,"value":27389.25,"ownership":{"direct":true},"balance_after":3700,"source":{"system":"sec-edgar","filing":"0001628280-21-010018","document":"wf-form4_162085127566189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021010018/wf-form4_162085127566189.xml","form_type":"4"}},{"id":2884607,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-02T20:22:50.000Z","date":"2021-01-29","kind":"purchase","acquired":true,"shares":1200,"price":16.03,"value":19236.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the purchase date."}],"balance_after":1200,"source":{"system":"sec-edgar","filing":"0001628280-21-001281","document":"wf-form4_161229735118364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021001281/wf-form4_161229735118364.xml","form_type":"4"}},{"id":2884606,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85667,"kind":"person","name":"Leversage Jill","position":1,"cik":"0001837374","reported_name":"Leversage Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-02-02T20:22:50.000Z","date":"2021-01-29","kind":"purchase","acquired":true,"shares":400,"price":16.03,"value":6412.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the purchase date."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001628280-21-001281","document":"wf-form4_161229735118364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021001281/wf-form4_161229735118364.xml","form_type":"4"}}]}